Life

Health, science, climate, and society-focused reporting.

Two Additional Drugmakers Participate in TrumpRx Initiative

The ongoing participation of two more drug manufacturers in the TrumpRx initiative highlights the evolving landscape of drug pricing and access, while Medicare delays continue to impact breakthrough device availability.

Editorial Staff Mar 16

Life

Structure Therapeutics' Obesity Pill Trial Yields Notable Weight Loss Results

A recent trial by Structure Therapeutics indicates a significant weight loss of 16% in patients using their daily obesity pill over 44 weeks, suggesting potential shifts in obesity treatment strategies.

Editorial Staff Mar 16

Life

CDC Staff with Disabilities Lack Necessary Accommodations

Despite ongoing discussions about health transformation, disabled staff at the CDC continue to face challenges in obtaining necessary workplace accommodations.

Editorial Staff Mar 16

Life

Structure Therapeutics Advances Mid-Stage GLP-1 Pill for Obesity Management

Structure Therapeutics has reported notable weight loss results from its mid-stage trial of a GLP-1 obesity pill, with plans for a Phase 3 study to follow.

Editorial Staff Mar 16

Life

Emerging Perfusion Technologies in Organ Transplantation: Challenges Ahead

Perfusion technology enhances organ quality for transplants, yet high costs and coverage uncertainties hinder its adoption as standard care.

Editorial Staff Mar 16

Life

Legislative Action Needed for Medicare Coverage of Innovative Medical Technologies

The call for bipartisan legislation to ensure Medicare covers breakthrough medical technologies is critical for infrastructure stability in healthcare.

Editorial Staff Mar 16

Life

Genetic Mutation and ALS: Implications for Healthcare Policy

The intersection of genetic predisposition to ALS and current healthcare policies raises concerns about future care and support systems.

Editorial Staff Mar 16

Life

Analyzing the Pharmaceutical Implications of 'The Fugitive' Drug Scandal

As Oscar season approaches, this report examines the potential infrastructure and regulatory challenges posed by a real-life drug scandal akin to that depicted in 'The Fugitive.'

Editorial Staff Mar 13

Life

Revised Cardiovascular Guidelines Advocate Early Cholesterol Risk Assessment

New cardiology guidelines recommend that adults as young as 30 evaluate their cholesterol levels and consider statin therapy to mitigate cardiovascular risks.

Editorial Staff Mar 13

Life

Pharmaceutical Industry Personnel Changes: Recent Hires and Departures

The pharmaceutical sector is experiencing notable personnel shifts, including new hires, promotions, and departures, impacting operational dynamics.

Editorial Staff Mar 13

Life

Medicare Advantage Plan Terminations in 2025: Infrastructure Implications for Beneficiaries

A significant majority of Medicare beneficiaries impacted by plan terminations in 2025 will have access to alternative Medicare Advantage plans in 2026, ensuring continuity of care.

Editorial Staff Mar 13

Life

Grail CEO Resigns Following Clinical Trial Challenges

The departure of Grail's CEO comes amid significant trial setbacks, raising questions about the company's strategic direction and operational capacity.

Editorial Staff Mar 13

Life

Analyzing Drug Pricing Strategies Under Trump and Biden

The ongoing discourse on drug pricing reveals contrasting strategies between the Trump and Biden administrations, with significant implications for the pharmaceutical infrastructure.

Editorial Staff Mar 13

Life

Five Essential Insights on Medicaid Prescription Drug Coverage

This brief outlines critical aspects of Medicaid prescription drug coverage, focusing on payment structures and administrative processes.

Editorial Staff Mar 13

Life

FDA Committee Recommends Development of Next Year's Flu Vaccines

The FDA committee has advised the formulation of flu vaccines for the upcoming year, addressing ongoing vaccine skepticism and related health issues.

Editorial Staff Mar 13

Life

Rising Public Concern Over Prescription Drug Affordability Signals Need for Systemic Changes

Recent polling indicates a significant increase in public anxiety regarding prescription drug costs, with bipartisan support for government intervention in pricing regulation.

Editorial Staff Mar 13

Life

Prescription Drug Affordability Concerns Highlighted by KFF Poll

A recent KFF Health Tracking Poll indicates that 59% of Americans express concern over prescription drug affordability, amidst ongoing regulatory discussions and the launch of the TrumpRx initiative.

Editorial Staff Mar 13

Life

Trump Gains Recognition for Drug Pricing Initiatives Over Biden

Former President Trump is receiving increased acknowledgment for his initiatives aimed at reducing drug prices, particularly through the TrumpRx program.

Editorial Staff Mar 13

Life

FDA Guidance on Flavored Vapes and Its Implications for Public Health Infrastructure

The FDA's new guidance on flavored vapes, including mint and coffee, may impact regulatory frameworks and public health strategies concerning youth vaping.

Editorial Staff Mar 13

Life

Legal Challenges Highlight Complexities in Hospital Quality Ratings

The recent legal defeat of the Leapfrog Group brings to light the intricate issues involved in assessing hospital safety and quality metrics.

Editorial Staff Mar 13